Flow cytometry sales will expand through 2036, with fluorescence technology at 70.0% within the technology segment and direct sales at 65.0% of the distribution channel category in 2026. The market was valued at USD 6.8 billion in 2025 and is forecast to record a 7.1% CAGR between 2026 and 2036.